Their results showed that immunization with mMSLN‐VLP vaccine can break the tolerance towards the self‐MSLN and induce specific CD8+ T cell response leading to tumor regression in an orthotopic pancreatic cancer murine model (Li et al., 2008). The gene discussed is CD8A; the disease is neoplasm.